1
|
Papasavvas E, Azzoni L, Ross BN, Fair M, Yuan Z, Gyampoh K, Mackiewicz A, Sciorillo AC, Pagliuzza A, Lada SM, Wu G, Goh SL, Bahnck-Teets C, Holder DJ, Zuck PD, Damra M, Lynn KM, Tebas P, Mounzer K, Kostman JR, Abdel-Mohsen M, Richman D, Chomont N, Howell BJ, Montaner LJ. Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral Therapy. Clin Infect Dis 2021; 72:495-498. [PMID: 33527127 DOI: 10.1093/cid/ciaa809] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2020] [Accepted: 06/12/2020] [Indexed: 02/06/2023] Open
Abstract
Accurate characterization of the human immunodeficiency virus (HIV) reservoir is imperative to develop an effective cure. HIV was measured in antiretroviral therapy-suppressed individuals using the intact proviral DNA assay (IPDA), along with assays for total or integrated HIV DNA, and inducible HIV RNA or p24. Intact provirus correlated with total and integrated HIV.
Collapse
Affiliation(s)
| | - Livio Azzoni
- Wistar Institute, Philadelphia, Pennsylvania, USA
| | - Brian N Ross
- Wistar Institute, Philadelphia, Pennsylvania, USA
| | - Matthew Fair
- Wistar Institute, Philadelphia, Pennsylvania, USA
| | - Zhe Yuan
- Wistar Institute, Philadelphia, Pennsylvania, USA
| | | | | | | | | | - Steven M Lada
- Veterans Affairs San Diego Healthcare System and the University of California, San Diego, California, USA
| | - Guoxin Wu
- Merck & Co., Inc., Kenilworth, New Jersey, USA
| | | | | | | | - Paul D Zuck
- Merck & Co., Inc., Kenilworth, New Jersey, USA
| | | | - Kenneth M Lynn
- Presbyterian Hospital, University of Pennsylvania hospital, Philadelphia, Pennsylvania, USA
| | - Pablo Tebas
- Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Karam Mounzer
- Jonathan Lax Immune Disorders Treatment Center, Philadelphia Field Initiating Group for HIV-1 Trials, Philadelphia, Pennsylvania, USA
| | - Jay R Kostman
- John Bell Health Center, Philadelphia Field Initiating Group for HIV-1 Trials, Philadelphia, Pennsylvania, USA
| | | | - Douglas Richman
- Veterans Affairs San Diego Healthcare System and the University of California, San Diego, California, USA
| | | | | | | |
Collapse
|